»ó´Ü¿©¹é
±â»ç (Àüü 947°Ç)
[Conference Report] ¡°S-¾Ï·ÎµðÇÉÀ¸·Î ÇÏÁöºÎÁ¾ ±Øº¹¡± ÀÓ¼¼Çü ±âÀÚ 2022-12-05 14:51
[Conference Report] ´ëÇÑ°íÇ÷¾ÐÇÐȸ 2022³â °íÇ÷¾Ð Áø·áÁöħ °ø°³ ÀÓ¼¼Çü ±âÀÚ 2022-12-05 14:47
[Late Breaking Studies] ¾Æ³ª±Û¸³Æ¾, Çѱ¹ÀÎ ´ë»ó ´ë±Ô¸ð ÀÓ»ó ÅëÇÑ

'°­·ÂÇÑ DPP-4¾ïÁ¦Á¦¡¯ ÀÔÁö È®ÀÎ

ÀÓ¼¼Çü ±âÀÚ 2022-12-05 13:24
[Interview] ¡°Æä³ëÇǺ극ÀÌÆ® Àå±âÅõ¿© ±Ù°Å ¸¶·ÃÇß´Ù¡± ÀÓ¼¼Çü ±âÀÚ 2022-11-16 11:47
[Conference Report] ¡°TZD, 1Â÷Àü·«À¸·Î °í·ÁÇؾߡ± ÀÓ¼¼Çü ±âÀÚ 2022-11-16 11:26
¶óÀÎ
[Conference Report] 3Á¦º´¿ë¿ä¹ý, Àå±â°£ È¿°ú ¹× ¾ÈÀü¼º º¸¿© ÀÓ¼¼Çü ±âÀÚ 2022-11-16 11:03
[Conference Report] ±¹³» SGLT-2¾ïÁ¦Á¦ À̳ªº¸±Û¸®Ç÷ÎÁø, ´Ù°¢µµÀÇ È¿°ú±Ù°Å ±¸Ãà ÀÓ¼¼Çü ±âÀÚ 2022-11-16 11:01
[Conference Report] ´ç´¢º´ ȯÀÚÀÇ CVD À§ÇèÀÎÀÚ Á¶ÀýÈ¿°ú ÀçÈ®ÀÎ ÀÓ¼¼Çü ±âÀÚ 2022-11-16 10:58
[Conference Report] SGLT-2i + DPP-4i Àü·«, Ç÷´çÁ¶Àý¡¤ÀáÀçÀû ½É±Ù ÇýÅà ±â´ë ÀÓ¼¼Çü ±âÀÚ 2022-11-16 10:54
[Deep in Guideline] [2022 ACC ºñ½ºÅ¸Æ¾¿ä¹ý Àü¹®°¡ ÄÁ¼¾¼­½º]

ºñ½ºÅ¸Æ¾ LDL-C °­ÇÏÀü·« ¾÷µ¥ÀÌÆ®

ÀÓ¼¼Çü ±âÀÚ 2022-11-16 10:52
¶óÀÎ
[Sub Story] Ç÷¾Ð°ú ½ÉºÎÀü µ¿½Ã °ü¸®Àü·« ¿ì¼± ¼±Åà ÀÓ¼¼Çü ±âÀÚ 2022-10-06 14:25
[Late Breaking Studies] ´ÙÆı۸®Ç÷ÎÁø ¡®Àü¹üÀ§¡¯ ½ÉºÎÀü Ä¡·áÀü·«À¸·Î ¹ßµ¸¿ò ÀÓ¼¼Çü ±âÀÚ 2022-10-06 11:07
[Conference Report] ¿þ¾î·¯ºí ÆÐÄ¡·Î ½ÉÀå ÃßÀû°üÂûÀÇ ½Ã°ø°£ ÇÑ°è ±Øº¹ ÀÓ¼¼Çü ±âÀÚ 2022-10-05 18:21
[Drug Review] CGMÀ¸·Î TIR °³¼±¡¤ÀúÇ÷´çÁõ À§Çè ÁÙ¿©¾ß ÀÓ¼¼Çü ±âÀÚ 2022-10-05 16:08
[Conference Report] ÁßÁõµµ´Â ³ôÀºµ¥¡¦ÀÎÁöµµ´Â Ã߶ô Áß ÀÓ¼¼Çü ±âÀÚ 2022-10-05 15:42
¶óÀÎ
[Deep in Guideline] SGLT-2¾ïÁ¦Á¦ HFmrEF¡¤HFpEF¿¡ ´äÀÌ µÇ´Ù ÀÓ¼¼Çü ±âÀÚ 2022-10-05 15:24
[Cover Story] Á¤½Å°Ç°­Áúȯ ¡®Ãʱâ°ü¸®¡¯¿¡¼­ ¹æÇâ Àâ´Â´Ù ÀÓ¼¼Çü ±âÀÚ 2022-09-05 18:17
[Sub Story] [Çѱ¹Çü ¿ì¿ïÀå¾Ö ¾à¹°Ä¡·á Áöħ¼­ 2021]
1´Ü°èºÎÅÍ ºñÁ¤Çü Ç×Á¤½Åº´¾à¹° °í·Á
ÀÓ¼¼Çü ±âÀÚ 2022-09-05 18:12
[Sub Story] [NICE ¼ºÀÎ ¿ì¿ïÁõ Ä¡·á¡¤°ü¸® °¡À̵å¶óÀÎ]
¾à¹°¿ä¹ý°ú ºñ¾à¹°¿ä¹ýÀÇ ÀûÀýÇÑ »ç¿ë °­Á¶
ÀÓ¼¼Çü ±âÀÚ 2022-09-05 18:04
[Sub Story] º¸¸£Æ¼¿Á¼¼Æ¾ MDD ¡®¸ÂÃãÄ¡·á¡¯ ±Ù°Å ´õÇß´Ù ÀÓ¼¼Çü ±âÀÚ 2022-09-05 17:49
Back to Top